Squamous Cell Carcinoma Including Actinic Keratosis, Bowen's Disease

Total Page:16

File Type:pdf, Size:1020Kb

Squamous Cell Carcinoma Including Actinic Keratosis, Bowen's Disease Chapter V.4 Squamous Cell Carcinoma Including Actinic Keratosis, Bowen’s Disease, V.4 Keratoacanthoma, and Its Pigmented Variants Iris Zalaudek, Jason S. Giacomel, Bernd Leinweber Contents glected, squamous cell carcinoma may cause local tissue destruction and may metastasize [2, V.4.1 Definition . .295 3]. Moreover, after the diagnosis of an initial V.4.2 Clinical Features . .296 squamous cell carcinoma, the 3-year cumula- V.4.2.1 Invasive Squamous Cell Carcinoma. 296 tive risk for developing a second lesion is ap- V.4.2.2 Actinic Keratosis. .296 proximately 18% [4], emphasizing the need for V.4.2.3 Bowen’s Disease. 297 ongoing clinical surveillance. In its pathogene- V.4.2.4 Keratoacanthoma. .297 sis, chronic ultraviolet (UV) irradiation plays a major role, responsible for DNA mutations (usu- V.4.3 Dermoscopic Criteria. 297 ally in the p53 tumor suppressor gene) in trans- V.4.3.1 Squamous Cell Carcinoma. .297 formed epidermal keratinocytes [5]. This ex- V.4.3.2 Actinic Keratosis. .298 plains why squamous cell carcinoma typically V.4.3.3 Bowen’s Disease. 298 develops on chronic sun-exposed body sites V.4.3.4 Keratoacanthoma. .299 such as the face or forearms of fair-skinned in- V.4.4 Relevant Clinical Differential dividuals. Besides fair skin phototype, male Diagnosis. 299 gender, and age over 40 years, organ-transplant V.4.5 Histopathology. .299 recipients represent a major risk group for squa- V.4.5.1 Squamous Cell Carcinoma. .299 mous cell carcinoma, having up to a 65-fold in- V.4.5.2 Actinic Keratosis. .299 creased risk for development compared with the V.4.5.3 Bowen’s Disease. 300 general population [6]. In this particular patient V.4.5.4 Keratoacanthoma. .300 group, 22% of squamous cell carcinomas will develop on sun-protected body sites such as the V.4.6 Management. .300 trunk or lower extremities. V.4.6.1 Squamous Cell Carcinoma. .300 So-called precursor lesions of squamous cell V.4.6.2 Actinic Keratosis. .300 carcinomas include actinic keratosis, Bowen’s V.4.6.3 Bowen’s Disease. 301 disease, and erythroplasia of Queyrat, although V.4.6.4 Keratoacanthoma. .301 a common etiological background is questioned, References. .301 based on differences in clinical, histopathologi- cal, and pathogenic profile. However, since these lesions are all epidermal neoplasias with a cer- tain potential of malignant progression, they V.4.1 Definition are commonly grouped within the spectrum of squamous cell carcinoma [7]. Invasive squamous cell carcinoma is the second Actinic keratoses are considered to be the most common skin cancer after basal cell carci- earliest form of squamous cell carcinoma, with noma and causes the majority of deaths among the risk of an individual lesion progressing to the non-melanoma skin malignancies. When invasive squamous cell carcinoma reported to detected and treated early squamous cell carci- vary from 0.1% up to a considerable 20% [8, 9]. noma has a 95% cure rate [1]; however, if ne- Nevertheless, even with a low individual rate of 296 I. Zalaudek, J.S. Giacomel, B. Leinweber progression, patients with multiple actinic kera- toses (i.e., more than 10) may have a 14% cumu- lative probability of developing squamous cell carcinoma, either within the actinic keratosis or de novo, within 5 years. This underscores the need for regular follow-up in these patients [8]. Bowen’s disease is a peculiar variant of squa- mous cell carcinoma in situ that frequently oc- curs in locations not exposed to solar irradia- tion. Consequently, some controversy exists regarding a common etiological background of Bowen’s disease and squamous cell carcinoma. Bowen’s disease differs significantly from ac- tinic keratosis and squamous cell carcinoma in Fig. V.4.1. Clinically, this invasive squamous cell car- its clinical and histopathological features as well cinoma presented as a pigmented and keratotic nodule in its pathogenesis, which is related to human located on the ear (antihelix) of a 78-year-old woman. papilloma virus infection, prior arsenic expo- Clinical differential diagnoses included of basal cell car- sure, radiation therapy, and internal malignan- cinoma, nodular–verrucous melanoma, and seborrheic keratosis. However, the lesion also had a history of recent cies, in addition to chronic UV exposure. In change, which increased the index of suspicion for ma- contrast, chronic UV irradiation is the primary lignancy and led to a punch biopsy of the lesion. Histo- carcinogen associated with actinic keratosis and pathology revealed a pigmented invasive a squamous cell squamous cell carcinoma [10, 11]. If left untreat- carcinoma and the lesion was subsequently excised ed for a variable period of time, Bowen’s disease may progress to a variant of invasive squamous cell carcinoma known Bowenoid carcinoma, in V.4.2.1 Invasive Squamous Cell 3–20% of cases [12, 13]. Remarkably, Bowenoid Carcinoma carcinoma may metastasize in up to one-third of cases, thus conferring a relatively poor prog- nosis[12]. Invasive squamous cell carcinoma typically oc- In further contrast, keratoacanthoma is also curs along with the presence of multiple actinic often cited as a “self-healing” variant of squa- keratoses. The initial, in-situ lesion is character- mous cell carcinoma, because it typically shows ized by a reddish, ill-defined plaque that may be a self-limiting course. Therefore, there is some difficult to distinguish from hyperkeratotic ac- question as to whether keratoacanthoma is a tinic keratosis. If left untreated, squamous cell true malignancy, or should be best regarded it as carcinoma in situ may progresses to invasive a benign “pseudocarcinoma” [14–16]. However, squamous cell carcinoma, which typically ap- reports which describe local tissue destruction pears as a firm, infiltrating, and often ulcerated and metastasis keratoacanthoma have led to a nodule, which enlarges fairly rapidly over a consideration of this tumor as a variant of squa- number of week or months. In addition, pig- mous cell carcinoma [17, 18]. Consequently bi- mented invasive squamous cell carcinoma may opsy and definitive treatment of keratoacantho- presents as a blue-to-black nodule with a scaly ma is generally recommended. surface (Fig. V.4.1). V.4 V.4.2 Clinical Features V.4.2.2 Actinic Keratosis Although the majority of these epidermal tu- Actinic keratoses appear as multiple macules, mors are usually non-pigmented, pigmented papules, or plaques surmounted by an adherent variants may also occur. surface scale, with some degree of erythema ranging from pale pink to dark red. Sometimes SCC and variants Chapter V.4 297 Fig. V.4.2. This pigmented actinic keratosis located on Fig. V.4.3. Keratoacanthoma typically develops rapidly the cheek of a 65-year-old man was clinically difficult to and presents clinically as a dome-shaped nodule with a distinguish from solar lentigo and lentigo maligna, espe- central plug of keratin, as seen in this image cially since it is a solitary pigmented macule lacking the typical surface scales or the neighboring sign with other lesions V.4.2.4 Keratoacanthoma actinic keratoses reveal a hyperkeratotic surface with crusts or erosions and may cause sensa- The clinical course of keratoacanthoma is typi- tions of burning or itching. Pigmented actinic fied by a rapid enlargement within a few weeks keratoses are less frequent but occur as light- to until a stabilization of growth is reached. After dark-brown irregular plaques or macules, usu- a variable time, a spontaneous involution results ally with a scaly surface. Pigmented actinic ker- in the regression of the lesion. The typical ap- atoses may clinically mimic solar lentigo, sebor- pearance of keratoacanthoma is that of a dome- rheic keratoses, pigmented Bowen’s disease, or shaped nodule of variable size characterized by lentigo maligna (Fig. V.4.2). a central crater filled with a mass of keratin. The diameter of a common solitary keratoacantho- ma can range from a few millimeters up to a V.4.2.3 Bowen’s Disease considerable 3 cm. Multiple lesions can occur spontaneously in the Gryzbowski variant, or in The clinical appearance of classical non-pig- Muir–Torre syndrome (Fig. V.4.3) [19–21]. mented Bowen’s disease is represented by a slowly growing, erythematous, well-demarcated plaque with a scaly or crusted surface that may V.4.3 Dermoscopic Criteria be eroded. Clinical differential diagnoses in- clude a variety of non-pigmented skin tumors V.4.3.1 Squamous Cell Carcinoma or erythemato-squamous skin disorders, such as actinic keratosis, basal cell carcinoma, amel- Dermoscopically, non-pigmented invasive squa- anotic melanoma, clear cell acanthoma, psoria- mous cell carcinoma frequently exhibits linear- sis, viral warts, and eczema, to name but a few. irregular, hairpin, or dotted vessels, or combina- In contrast, pigmented Bowen’s disease is less tions thereof (the so-called polymorphous or common and presents clinically as a non-uni- atypical vascular pattern) [22]. Typically, these formly pigmented plaque with a scaly or verru- vessels are surrounded by a whitish halo, which cous surface which should be differentiated is a dermoscopic hallmark of all keratinizing tu- from seborrheic keratosis, pigmented actinic mors. Ulceration and blood crusts, if present, ap- keratosis, solar lentigo, basal cell carcinoma, pear as irregularly distributed reddish to brown- blue nevus, melanocytic nevi, and melanoma. ish to black blotches on the surface of the tumor. 298 I. Zalaudek, J.S. Giacomel, B. Leinweber Fig. V.4.4. Dermoscopy of the pigmented invasive squa- Fig. V.4.5. Dermoscopy of the pigmented actinic kerato- mous cell carcinoma, as shown in Fig. V.4.1. reveals sur- sis depicted in Fig. V.4.2 reveals the same features as len- face scale, a blue-white veil and irregular brown-to-black tigo maligna, characterized by rhomboidal structures and blotches.
Recommended publications
  • Glossary for Narrative Writing
    Periodontal Assessment and Treatment Planning Gingival description Color: o pink o erythematous o cyanotic o racial pigmentation o metallic pigmentation o uniformity Contour: o recession o clefts o enlarged papillae o cratered papillae o blunted papillae o highly rolled o bulbous o knife-edged o scalloped o stippled Consistency: o firm o edematous o hyperplastic o fibrotic Band of gingiva: o amount o quality o location o treatability Bleeding tendency: o sulcus base, lining o gingival margins Suppuration Sinus tract formation Pocket depths Pseudopockets Frena Pain Other pathology Dental Description Defective restorations: o overhangs o open contacts o poor contours Fractured cusps 1 ww.links2success.biz [email protected] 914-303-6464 Caries Deposits: o Type . plaque . calculus . stain . matera alba o Location . supragingival . subgingival o Severity . mild . moderate . severe Wear facets Percussion sensitivity Tooth vitality Attrition, erosion, abrasion Occlusal plane level Occlusion findings Furcations Mobility Fremitus Radiographic findings Film dates Crown:root ratio Amount of bone loss o horizontal; vertical o localized; generalized Root length and shape Overhangs Bulbous crowns Fenestrations Dehiscences Tooth resorption Retained root tips Impacted teeth Root proximities Tilted teeth Radiolucencies/opacities Etiologic factors Local: o plaque o calculus o overhangs 2 ww.links2success.biz [email protected] 914-303-6464 o orthodontic apparatus o open margins o open contacts o improper
    [Show full text]
  • In Dermatology Visit with Me to Discuss
    From time to time new treatments surface for any medical field, and the last couple of years have seen new treatments emerge, or new applications for familiar treatments. I wanted to summarize some of these New Therapies widely available remedies and encourage you to schedule a in Dermatology visit with me to discuss. Written by Board Certified Dermatologist James W. Young, DO, FAOCD Nicotinamide a significant reduction in melanoma in Antioxidants Nicotinamide (niacinamide) is a form high risk skin cancer patients at doses Green tea, pomegranate, delphinidin of vitamin B3. The deficiency of vitamin more than 600 and less than 4,000 IU and fisetin are all under current study for daily. B3 causes pellagra, a condition marked either oral or topical use in the reduction by 4D’s – (photo) Dermatitis, Dementia, Polypodium Leucotomos of the incidence of skin cancer, psoriasis Diarrhea and (if left untreated) Death. and other inflammatory disorders. I’ll be Polypodium leucotomos is a Central This deficiency is rare in developed sure to keep patients updated. countries, but is occasionally seen America fern that is available in several in alcoholism, dieting restrictions, or forms, most widely as Fernblock What Are My Own Thoughts? malabsorption syndromes. Nicotinamide (Amazon) or Heliocare (Walgreen’s and I take Vitamin D 1,000 IU and Heliocare does not cause the adverse effects of Amazon) and others. It is an antioxidant personally. Based on new research, I Nicotinic acid and is safe at doses up to that reduces free oxygen radicals and have also added Nicotinamide which 3,000mg daily. may reduce inflammation in eczema, dementia, sunburn, psoriasis, and vitiligo.
    [Show full text]
  • Pilar Sheath Acanthoma Presenting As a Nevus
    Letter to Editor Pilar Sheath Acanthoma Presenting as a Nevus Sir, Pilar sheath acanthoma (PSA) is a rare benign follicular neoplasm, which was first described by Mehregan and Brownstein in 1978.[1] PSA usually presents as an asymptomatic, flesh colored papule with a central opening localized at the lower lip with exceptional presentations such as ear lobe, postauricular region, or cheek.[1‑3] A 42‑year‑old female referred with a solitary, slow‑growing nodular lesion at the upper lip region for 6 months. Physical exam revealed a 4 mm, pink‑brown colored nodule with a central opening [Figure 1]. Under clinical prediagnosis of melanocytic nevus, an excisional biopsy Figure 1: Physical examination of the nodule in the upper lip region was performed. In a microscopic examination, a cystic cavity that communicated with surface epidermis has been observed. The wall of the cystic cavity was composed of solid tumor islands extending in the deep dermis [Figure 2]. The cavity was lined with stratified squamous epithelium filled with keratin [Figure 3]. PSA is an uncommon, benign follicular tumor occurring in the faces of middle‑aged and elderly patients. These lesions can present at any location such as cheek, ear lobe on the head, and neck. In our case, a 42‑year‑old female was presented with a pink‑brown colored nodular lesion opening at the upper lip region. The differential diagnosis includes trichofolliculoma and dilated pore of Winer. Trichofolliculomas contain many seconder hair follicles Figure 2: A central cavity with keratin in the dermis which is continuous radiating from the wall of the primary follicle with outer with the surface epithelium (H and E, ×40) and inner root sheaths in a well‑formed stroma which are absent in PSA.
    [Show full text]
  • Actinic Keratoses Final Report
    Actinic Keratoses Final Report Mark Helfand, MD, MPH Annalisa K. Gorman, MD Susan Mahon, MPH Benjamin K.S. Chan, MS Neil Swanson, MD Submitted to the Agency for Healthcare Research and Quality under contract 290-97-0018, task order no. 6 Oregon Health & Science University Evidence-based Practice Center 3181 SW Sam Jackson Park Road Portland, Oregon 97201 May 19, 2001 Actinic Keratoses Structured Abstract Objective: To examine evidence about the natural history and management of actinic keratoses (AKs). Search Strategy: We searched the MEDLINE database from January 1966 to January 2001, the Cochrane Controlled Trials Registry, and a bibliographic database of articles about skin cancer. We identified additional articles from reference lists and experts. Selection Criteria: We selected 45 articles that contained original data relevant to treatment of actinic keratoses, progression of AKs to squamous cell cancer (SCC ), means of identifying a high-risk group, or surveillance of patients with AKs to detect and treat SCCs early in their course. Data Collection and Analysis: We abstracted information from these studies to construct evidence tables. We also developed a simple mathematical model to examine whether estimates of the rate of progression of AK to SCC were consistent among studies. Finally, we analyzed data from the Medicare Statistical System to estimate the frequency of procedures attributable to AK among elderly beneficiaries. Main Results: The yearly rate of progression of an AK in an average-risk person in Australia is between 8 and 24 per 10,000. High-risk individuals with multiple AKs have progression rates as high as 12-30 percent over 3 years.
    [Show full text]
  • The Tamilnadu Dr. M.G.R. Medical University Chennai, Tamil Nadu
    CLINICO-PATHOLOGICAL STUDY OF SKIN SURFACE EPIDERMAL AND APPENDAGEAL TUMOURS Dissertation Submitted in partial fulfillment of university regulations for M.D. DEGREE IN DERMATOLOGY, VENEREOLOGY AND LEPROSY BRANCH XII – A THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY CHENNAI, TAMIL NADU SEPTEMBER 2006 CERTIFICATE This is to certify that this Dissertation entitled “CLINICO-PATHOLOGICAL STUDY OF SKIN SURFACE EPIDERMAL AND APPENDAGEAL TUMOURS” is a bonafide work done by DR.G.BALAJI, Postgraduate student of Department of Dermatology, Leprosy and Institute of STD, Madras Medical College and Government General Hospital, Chennai – 3 for the award of Degree of M.D.( Dermatology, Venereology and Leprosy ) Branch XII – A during the academic year of 2003-2006. This work has not previously formed in the basis for the award of any degree or diploma. Prof. Dr. B. Parveen, MD., DD., Professor & Head, Dept. of Dermatology and Leprosy, Madras Medical College & Govt. General Hospital, Chennai – 3. Prof. Dr. Kalavathy Ponniraivan, MD., The Dean Madras Medical College & Govt. General Hospital, Chennai – 3. SPECIAL ACKNOWLEDGEMENT I sincerely thank Prof. Dr. Kalavathy Ponniraivan, MD., Dean, Madras Medical College & Govt. General Hospital, Chennai – 3, for granting me permission to use the resources of this institution for my study. ACKNOWLEDGEMENT I sincerely thank Prof. B.Parveen MD.,DD, Professor and Head of Department of Dermatology for her invaluable guidance and encouragement for the successful completion of this study. I express my heart felt gratitude to Dr.N.Gomathy MD.,DD, former Head of department of Dermatology who was instrumental in the initiation of this project, giving constant guidance throughout my work.
    [Show full text]
  • What Are Basal and Squamous Cell Skin Cancers?
    cancer.org | 1.800.227.2345 About Basal and Squamous Cell Skin Cancer Overview If you have been diagnosed with basal or squamous cell skin cancer or are worried about it, you likely have a lot of questions. Learning some basics is a good place to start. ● What Are Basal and Squamous Cell Skin Cancers? Research and Statistics See the latest estimates for new cases of basal and squamous cell skin cancer and deaths in the US and what research is currently being done. ● Key Statistics for Basal and Squamous Cell Skin Cancers ● What’s New in Basal and Squamous Cell Skin Cancer Research? What Are Basal and Squamous Cell Skin Cancers? Basal and squamous cell skin cancers are the most common types of skin cancer. They start in the top layer of skin (the epidermis), and are often related to sun exposure. 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 Cancer starts when cells in the body begin to grow out of control. Cells in nearly any part of the body can become cancer cells. To learn more about cancer and how it starts and spreads, see What Is Cancer?1 Where do skin cancers start? Most skin cancers start in the top layer of skin, called the epidermis. There are 3 main types of cells in this layer: ● Squamous cells: These are flat cells in the upper (outer) part of the epidermis, which are constantly shed as new ones form. When these cells grow out of control, they can develop into squamous cell skin cancer (also called squamous cell carcinoma).
    [Show full text]
  • Prior Authorization Criteria
    PRIOR AUTHORIZATION CRITERIA Last Updated 09/01/2021 This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered under your medical or prescription drug benefit. Please verify drug coverage by checking your formulary and member handbook. Additional restrictions and exclusions may apply. If you have questions, please contact Providence Health Plan Customer Service at 503-574-7500 or 1-800-878-4445 (TTY: 711). Service is available five days a week, Monday through Friday, between 8 a.m. and 6 p.m. ACTINIC KERATOSIS AGENTS MEDICATION(S) CARAC, FLUOROURACIL 0.5% CREAM, IMIQUIMOD 3.75% CREAM, IMIQUIMOD 3.75% CREAM PUMP, KLISYRI, PICATO, TOLAK, ZYCLARA COVERED USES N/A EXCLUSION CRITERIA • Treatment of basal cell carcinoma or other skin cancers REQUIRED MEDICAL INFORMATION 1. For the treatment of Actinic Keratosis (AK): Documentation of trial and failure*, contraindication or intolerance to two of the following formulary, generic topical agents: a. Diclofenac 3% gel b. 5-fluorouracil 2% or 5% cream/solution c. Imiquimod 5% cream *An adequate trial and failure is defined as failure to achieve clearance of AK lesion(s) after adherence to recommended treatment dosing and duration Reauthorization: Requires documentation of a reduction in the number and/or size of lesions of AK and medical rationale for continuing therapy beyond recommended treatment course. 1. For the treatment of external genital and perianal warts/condyloma acuminate (Zyclara® 3.75% only): Documentation of trial and failure*, contraindication, or intolerance to formulary, generic imiquimod 5% cream.
    [Show full text]
  • What to Expect Following Cryosurgery “Freezing”
    What to Expect Following CryoSurgery “Freezing” What is Cryosurgery? Cryosurgery is a technique for removing skin lesions that primarily involve the surface of the skin, such as warts, seborrheic keratosis, or actinic keratosis. It is a quick method of removing the lesions with minimal scarring. The liquid nitrogen needs to be applied long enough to freeze the affected skin. By freezing the skin, a blister is created underneath the lesion. Ideally, as the new skin forms underneath the blister, the abnormal skin on the roof of the blister peels off. Occasionally if the lesion is very thick (such as a large wart), only the surface is blistered off. The base or residual lesion may need to be frozen at another visit. What to Expect Over the Next Few Weeks? During Treatment – Area being treated will sting, burn and then possibly itch. Immediately After Treatment – Area will be red sore and swollen. Next Day- Blister or blood blister has formed, tenderness starts to subside. Apply a Band-Aid if necessary. 7 Days- Surface is dark red/brown and scab-like. Apply Vaseline or an antibacterial ointment if necessary. 2 to 4 Weeks- The surface starts to peel off. This may be encouraged gently during bathing, when the scab is softened. No makeup should be applied until area is fully healed. How to Take care of the Skin after Cryosurgery A Band-Aid can be used for larger blisters or blisters in areas that are more likely to be traumatized- such as fingers and toes. If the area becomes dry or crusted, an ointment (Vaseline, Aquaphor) can also be applied.
    [Show full text]
  • Hair Follicle Tumors
    Hair Follicle Tumors 803-808-7387 www.gracepets.com These notes are provided to help you understand the diagnosis or possible diagnosis of cancer in your pet. For general information on cancer in pets ask for our handout “What is Cancer”. Your veterinarian may suggest certain tests to help confirm or eliminate diagnosis, and to help assess treatment options and likely outcomes. Because individual situations and responses vary, and because cancers often behave unpredictably, science can only give us a guide. However, information and understanding for tumors in animals is improving all the time. We understand that this can be a very worrying time. We apologize for the need to use some technical language. If you have any questions please do not hesitate to ask us. What is this tumor? This is one of many similar tumors that arise by disordered growth of the hair follicles. These tumors are almost all benign and can be permanently cured by total surgical removal. Some occur at multiple sites within the same animal. This family of tumors grade into each other. Precise nomenclature is usually irrelevant as almost all are benign. What do we know about the cause? The reason why a particular pet may develop this, or any cancer, is not straightforward. Cancer is often seemingly the culmination of a series of circumstances that come together for the unfortunate individual. Cross Section of Skin & Hair Follicle B-catenin is required for differentiation of skin cells into hair follicles. If there is over-production of this chemical in the body, hair follicle tumors develop.
    [Show full text]
  • Expert-Level Diagnosis of Nonpigmented Skin Cancer by Combined Convolutional Neural Networks
    Supplementary Online Content Tschandl P, Rosendahl C, Akay BN, et al. Expert-level diagnosis of nonpigmented skin cancer by combined convolutional neural networks. JAMA Dermatol. Published online November 28, 2018. doi:10.1001/jamadermatol.2018.4378 eFigure. Sensitivities (Blue) and Specificities (Orange) at Different Threshold Cutoffs (Green) of the Combined Classifier Evaluated on the Validation Set eAppendix. Neural Network Training eTable 1. Complete List of Diagnoses and Their Frequencies Within the Test-Set eTable 2. Education of Users According to Their Experience Group eTable 3. Percent of Correct Prediction of the Malignancy Status for Specific Diagnoses of a CNN Using Either Close-up or Dermatoscopic Images This supplementary material has been provided by the authors to give readers additional information about their work. © 2018 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/25/2021 eFigure. Sensitivities (Blue) and Specificities (Orange) at Different Threshold Cutoffs (Green) of the Combined Classifier Evaluated on the Validation Set A threshold cut at 0.2 (black) is found for a minimum of 51.3% specificity. © 2018 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/25/2021 eAppendix. Neural Network Training We compared multiple architecture and training hyperparameter combinations in a grid-search fashion, and used only the single best performing network for dermoscopic and close-up images, based on validation accuracy, for further analyses. We trained four different CNN architectures (InceptionResNetV2, InceptionV3, Xception, ResNet50) and used model definitions and ImageNet pretrained weights as available in the Tensorflow (version 1.3.0)/ Keras (version 2.0.8) frameworks.
    [Show full text]
  • Lumps & Bumps: Approach to Common Dermatologic Neoplasms
    Case-Based Approach to Common Dermatologic Neoplasms Patrick Retterbush, MD, FAAD Mohs Surgery & Dermatologic Oncology Associate Member of the American College of Mohs Surgery Private Practice: Lockman Dermatology January 27th 2018 Disclosure of Relevant Financial Relationships • I do not have any relevant financial relationships, commercial interests, and/or conflicts of interest regarding the content of this presentation. Goals/Objectives • Recognize common benign growths • Recognize common malignant growths • Useful clues & examination for evaluating melanocytic nevi and when to be concerned for melanoma/atypical moles • How to perform a basic skin biopsy and which method/type to choose • Basic treatment/when to refer Key Questions & Physical Examination Findings for a Growth History Physical Examination • How long has the lesion been • Describing a growth present? – flat or raised? • flat – macule (<1cm) or patch (>1cm) – years, months, weeks • raised – papule (<1cm) or plaque (>1cm) – nodule if deep (majority of lesion in • Has it changed? dermis/SQ) – Size – secondary descriptive features • scaly (hyperkeratosis, retention of strateum – Shape corneum) – Color • crusty (dried serum, blood, or pus on surface) • eroded or ulcerated (partial vs. full thickness – Symptoms – pain, bleeding, itch? epidermal loss) – Over what time frame? • color (skin colored, red, pigmented, pearly) • feel (hard or soft, mobile or fixed) • PMH: • size: i.e. 6 x 4mm – prior skin cancers • Look at the rest of the skin/region of skin • SCC/BCCs vs. melanoma
    [Show full text]
  • A Case of Polypoid Clear Cell Acanthoma on the Nipple
    Ann Dermatol Vol. 22, No. 3, 2010 DOI: 10.5021/ad.2010.22.3.337 CASE REPORT A Case of Polypoid Clear Cell Acanthoma on the Nipple Se Young Park, M.D.1, Jae Yoon Jung, M.D.1, Jung Im Na, M.D.1,2, Hee Jin Byun, M.D.1, Kwang Hyun Cho, M.D.1 Departments of Dermatology, 1Seoul National University College of Medicine, Seoul, 2Seoul National University Bundang Hospital, Seongnam, Korea Clear cell acanthoma (CCA) is a rare benign epidermal mon features include parakeratosis and infiltration of the tumor. It usually presents as a flat nodule or dome-shaped epidermis by neutrophils3. plaque and is often localized on the legs of the elderly. We At present, a few cases of CCA on the nipple area have observed an unusual case of polypoid CCA on the nipple of been reported in the literature4-6. Unlike typical CCA, CCA a 14-year-old girl. At present, a few cases of CCA on the on the nipple area usually presents as chronic eczema nipple area have been reported in the literature. However, rather than as a papule or plaque6. However, CCA as a CCA presented as a polypoid tumor on the nipple area has polypoid tumor on the nipple area has very rarely been been reported very rarely. We herein report the very rare reported. We herein report the rare case of polypoid CCA case of polypoid CCA on the nipple and suggest that CCA on the nipple and suggest that CCA should be included in should be included in the clinical differential diagnosis of the clinical differential diagnosis of polypoid lesions on polypoid lesions on the nipple.
    [Show full text]